One of several epileptic diseases associated with defects in human genes KCNT1 or KCNT2, orthologous to Dmel\SLO2. See human disease model report for seizure-sensitive, potassium channel defects, KCNT1-2-related (FBhh0001405).
[updated Nov. 2021 by FlyBase; FBrf0222196]
[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 57; DEE57](https://omim.org/entry/617771)
[POTASSIUM CHANNEL, SUBFAMILY T, MEMBER 2; KCNT2](https://omim.org/entry/610044)
Developmental and epileptic encephalopathy-57 (DEE57) is a neurologic disorder characterized by global developmental delay with hypotonia, variably impaired intellectual development, and poor or absent language. Affected individuals have onset of refractory multifocal seizures in the first days or months of life, and may show developmental regression. EEG patterns include hypsarrhythmia, suggesting a clinical diagnosis of West syndrome, background slowing, and epilepsy of infancy with migrating focal seizures (EIMFS). Some patients may have mild dysmorphic features (summary by Ambrosino et al., 2018, pubmed:29740868; Mao et al., 2020, pubmed:32038177). [from MIM:617771; 2021.11.11]
Developmental and epileptic encephalopathy-57 (DEE57) is caused by heterozygous mutation in the KCNT2 gene. [from MIM:617771; 2021.11.11]
KCNT2 encodes an outwardly rectifying potassium channel subunit; activated by high intracellular sodium or calcium levels. Produces rapidly activating outward rectifier K(+) currents.[Gene Cards, KCNT2; 2021.11.11]